Skip to main content
Clinical Trials/TCTR20200425004
TCTR20200425004
Completed
N/A

Evaluation of peri-implant crevicular fluid biomarkers and marginal bone loss in platform-switched and non-platform-switched implants: a randomised prospective clinical study

istanbul university scientific research project0 sites27 target enrollmentApril 25, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
missing teeth
Sponsor
istanbul university scientific research project
Enrollment
27
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 25, 2020
End Date
September 1, 2015
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
istanbul university scientific research project

Eligibility Criteria

Inclusion Criteria

  • an implant site without acute infection or bone defects; a bone crest ≥7 mm; a full\-mouth plaque score (modified plaque index \[mPI]) and full\-mouth bleeding score (bleeding on probing \[BOP]) ≤25%; ≤10 cigarettes per day if a smoker; and a peri\-implant keratinised tissue width ≥2 mm.

Exclusion Criteria

  • systemic medical conditions such as diabetes and any medication that could influence healing of soft or hard tissue.
  • full\-mouth plaque score (modified plaque index \[mPI]) and full\-mouth bleeding score (bleeding on probing \[BOP]) more than 25%; 10 and more cigarettes per day if a smoker; and a peri\-implant keratinised tissue width less than 2 mm.

Outcomes

Primary Outcomes

Not specified

Similar Trials